Zum Inhalt springen

Nur-Lesen-Fassung: Das Forschungsinformationssystem (FIS) ist aus Sicherheitsgründen vorübergehend durch diese Nur-Lesen-Fassung ersetzt. Alle öffentlichen Inhalte und Volltexte sind weiterhin abrufbar; Anmeldung, Bearbeitung, Einreichung und Statistiken stehen nicht zur Verfügung. Bei Fragen: fis@uni-bamberg.de

Start › Publikationen › Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance : cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study

Publikation

Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance : cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study

Ehrmann, Dominic; Krause-Steinrauf, Heidi; Uschner, Diane; u. a. (2025): Differential associations of somatic and cognitive-affective symptoms of depression with inflammation and insulin resistance : cross-sectional and longitudinal results from the Emotional Distress Sub-Study of the GRADE study, in: Bamberg: Otto-Friedrich-Universität, S. 1403–1415.

Details

Fakultät/Lehrstuhl
Autorin(nen)/Autor(en)
ORCID iDEhrmann, Dominic; Krause-Steinrauf, Heidi; Uschner, Diane; Wen, Hui; Hoogendoorn, Claire J.; Crespo-Ramos, Gladys; Presley, Caroline; Arends, Valerie L.; Cohen, Robert M.; Garvey, W. Timothy; Martens, Thomas; Willis, Holly J.; Cherrington, Andrea; Gonzalez, Jeffrey S.
Verlagsangabe
Otto-Friedrich-Universität : Bamberg
Erscheinungsjahr
2025
Quelle/Weitere Ausgabe
Diabetologia : journal of the European Association for the Study of Diabetes (EASD), Berlin ; Heidelberg: Springer, Jg. 68, Nr. 7, S. 1403–1415, ISSN: 1432-0428, 0012-186X
Jahr der Erstpublikation
2025
Sprache(n)
Englisch
Lizenz
URN
Abstract

Aims/hypothesis:

Insulin resistance and inflammation are components of a biological framework that is hypothesised to be shared by type 2 diabetes and depression. However, depressive symptoms include a large heterogeneity of somatic and cognitive-affective symptoms, and this may obscure the associations within this biological framework. Cross-sectional and longitudinal data were used to disentangle the contributions of insulin resistance and inflammation to somatic and cognitive-affective symptoms of depression.

Methods:

This secondary analysis used data from the Emotional Distress Sub-Study of the GRADE trial. Insulin resistance and inflammation were assessed using the HOMA-IR estimation and high-sensitivity C-reactive protein (hsCRP) levels, respectively, at baseline and at the study visits at year 1 and year 3 (HOMA-IR) and every 6 months (hsCRP) for up to 3 years of follow-up. Depressive symptoms were assessed at baseline using the Patient Health Questionnaire (PHQ-8), and a total score as well as symptom cluster scores for cognitive-affective and somatic symptoms were calculated. For the cross-sectional analyses, linear regression analyses were performed, with inflammation and insulin resistance at baseline as dependent variables. For the longitudinal analyses, linear mixed-effect regression analyses were performed, with inflammation and insulin resistance at the various time points as dependent variables. In all analyses, depressive symptoms (total score and symptom cluster scores) were the independent variables, controlled for important demographic, anthropometric and metabolic confounders. For the analysis of insulin resistance (HOMA-IR), data from 1321 participants were analysed. For the analysis of inflammation (hsCRP), data from 1739 participants were analysed.

Results:

In cross-sectional analysis and after adjustment for potential confounders, a one-unit increase in PHQ-8 total score was significantly associated with a 0.8% increase in HOMA-IR (p=0.007), but not with hsCRP (0.6% increase, p=0.283). The somatic symptom score was associated with a 5.8% increase in HOMA-IR (p=0.004). Single-item analyses of depressive symptoms showed that fatigue (3.6% increase, p=0.002) and increased/decreased appetite (3.5% increase, p=0.009) were significantly associated with HOMA-IR cross-sectionally. The cognitive-affective symptom score was not significantly associated with HOMA-IR at baseline. In longitudinal analyses, a one-unit increase in PHQ-8 total score was significantly associated with a 0.8% increase in hsCRP over time (p=0.014), but not with HOMA-IR over time (0.1% decrease, p=0.564). Again, only the somatic symptom cluster was significantly associated with hsCRP over time (5.2% increase, p=0.017), while the cognitive-affective symptom score was not.

Conclusion/interpretation:

The results highlight the associations of depressive symptoms with markers of inflammation and insulin resistance, both cross-sectionally and longitudinally, in individuals with type 2 diabetes. In particular, somatic symptoms of depression appear to be the driver of these associations, even after controlling for concomitant conditions, with a potential role for fatigue and issues with appetite.

Trial registration: ClinicalTrials.gov NCT01794143

Freie Schlagwort(e)
Depression
Inflammation
Insulin resistance
Somatic symptoms
Type 2 diabetes
DDC-Klassifikation
150 Psychologie
RVK-Klassifikation
CU 3200
Dokumenttyp
Artikel in einer Zeitschrift / Postprint
URI
Datum der Freischaltung
18.07.2025
Projekt(e)

Permalink: https://fis.uni-bamberg.de/handle/uniba/108867 · Daten als JSON · Zitieren: BibTeX · RIS

Datenstand: 15.11.2026

Eingeschränkter Lesezugriff: Anmeldung, Bearbeitung und Einreichung sind vorübergehend deaktiviert.